BusinessINVESTORS SAY EXECUTIVE PAY PACKAGES AT PHARMA MAY INCENTIVIZE DRUG PRICING RISKSBy Nasdaq OMXDec 13, 2017, 6:13 PM UTC
BusinessStreetwise Reports Examines Promising 'Hot' Alzheimer's Market for Biotech with 'Novel' Drug CandidateBy Nasdaq OMXNov 23, 2017, 1:45 PM UTC